Latest Breaking News On - Taichu biotechnology - Page 1 : comparemela.com

Rgenta Therapeutics has snagged $60 million in a Series A round participated by Highlight Capital, while IDG Capital has led Taichu Biotech‘s $58m Series A.  

United statesLingang life science blue bay fundShanghai lingang economic development groupBoehringer ingelheim venture fundRgenta therapeuticsHighlight capitalTaichu biotechnologyLilly asia venturesVivo capitalMatrix partnersShanghai healthcare capitalBoquan equity investment managementAopeng investmentApricot capitalYijing capitalNeux capital